martin
dm
boy
cw
ruf
w
tissu
factor
molecular
recognit
cofactor
function
faseb
j
banner
dw
darci
chene
c
winkler
fk
guha
konigsberg
wh
nemerson
kirchhof
crystal
structur
complex
blood
coagul
factor
viia
solubl
tissu
factor
natur
lewi
jh
compar
hemostasi
verterbr
new
york
plenum
press
tuddenham
eg
pemberton
cooper
dn
becom
evid
coagul
factor
differ
factor
vii
ix
requir
activ
prothrombin
thrombin
found
coagul
properti
blood
sampl
patient
thought
lack
factor
vii
call
proconvertin
could
normal
mix
sampl
indic
diseas
homogen
entiti
new
factor
factor
x
also
call
stuart
factor
prower
factor
factor
x
found
requir
vitamin
k
normal
biosynthesi
treatment
patient
vitamin
k
antagonist
dicoumarol
warfarin
result
decreas
biolog
activ
first
purifi
homogen
bovin
plasma
later
human
plasma
factor
x
zymogen
serin
proteas
activ
enzym
factor
xa
argspecif
serin
proteas
relat
trypsin
much
narrow
substrat
specif
ntermin
acid
gla
domain
bind
calcium
ion
cooper
manner
averag
k
b
mm
mediat
interact
factor
xxa
phospholipid
membran
presenc
calcium
ion
factor
xa
form
phospholipidbound
complex
cofactor
factor
va
prothrombinas
complex
activ
prothrombin
chapter
rapidli
free
factor
xa
studi
reaction
demonstr
phospholipid
reduc
k
prothrombin
wherea
factor
va
increas
v
max
vivo
surfac
activ
platelet
main
site
prothrombinas
complex
assembl
factor
va
deriv
factor
v
specif
proteolyt
cleavag
mediat
thrombin
factor
xa
membranebound
factor
va
bind
factor
xa
high
affin
k
b
nm
due
least
part
interact
catalyt
domain
residu
residu
factor
va
measur
affin
zymogen
absenc
factor
va
factor
xa
bind
phospholipid
membran
k
nm
reaction
phospholipid
regard
mean
reduc
dimension
reaction
three
two
dimens
therebi
increas
likelihood
product
collis
factor
xa
membranebound
factor
va
effect
bind
factor
xxa
membran
requir
phosphatidylserin
expos
outer
surfac
occur
vesicl
releas
activ
platelet
phosphatidylserin
transloc
exterior
phospholipid
scramblas
platelet
activ
regulatori
mechan
restrict
bind
factor
xxa
discret
type
cell
accord
function
state
factor
xa
activ
prothrombin
singlechain
molecul
hydrolyz
two
peptid
bond
reaction
may
thu
proceed
via
two
pathway
one
pathway
cleavag
bond
yield
intermedi
meizothrombin
may
cleav
bond
yield
fragment
thrombin
cleavag
prothrombin
meizothrombin
bind
exosit
impair
structur
shift
accompani
activ
thrombin
prevent
cleavag
meizothrombin
meizothrombin
inact
fibrinogen
readili
activ
protein
c
chapter
second
pathway
initi
cleavag
occur
bond
intermedi
fragment
form
enzymat
inact
form
predominantli
absenc
factor
va
subsequ
hydrolysi
bond
yield
thrombin
bond
also
suscept
cleavag
factor
xa
thrombin
plasma
site
may
prefer
arg
bond
vitro
factor
va
andor
phosphatidylserin
modul
specif
factor
xa
meizothrombin
pathway
predomin
gener
thought
physiolog
relev
activ
pathway
factor
xa
also
proteolyt
activ
factor
v
viii
factor
vii
chapter
thu
particip
posit
feedback
loop
amplifi
clot
process
factor
xa
also
inactiv
factor
viiia
cleavag
within
subunit
sever
synthet
substrat
avail
factor
xa
includ
methoxycarbonylcyclohexylglycylglyargknhphno
spectrozym
xa
methanesulfonyldleuglyargknhphno
cb
bzileglu
piperidin
amid
glyargknhphno
full
activ
factor
xa
toward
substrat
requir
presenc
na
ca
ion
modul
catalyt
domain
subsit
specif
examin
detail
use
proteomederiv
peptid
librari
phage
display
fluorescencequench
substrat
reveal
prefer
arg
gli
ala
slight
prefer
pro
small
amino
acid
asp
aromat
aliphat
residu
especi
phe
leu
tyr
free
factor
xa
bloodstream
rapidli
inactiv
serin
proteas
inhibitor
serpin
antithrombin
proteas
inhibitor
cleavag
expos
loop
serpin
factor
xa
lead
format
covalentlylink
complex
stoichiometri
inhibit
enzymat
activ
rate
inactiv
antithrombin
increas
sever
thousandfold
heparin
heparin
sulfat
shorter
heparinbas
synthet
oligosaccharid
sulfat
galactan
red
alga
botryocladia
occidentali
anoth
serpin
protein
zdepend
proteas
inhibitor
zpi
inhibit
factor
xa
although
far
less
effect
antithrombin
unfavor
tyr
residu
factor
xa
essenti
inhibit
zpi
identifi
autolysi
loop
heparin
bind
exosit
protein
z
acceler
inhibit
interact
zpi
requir
associ
membran
interact
gla
domain
protein
z
zpi
protein
z
pseudoact
site
factor
xa
also
inhibit
nonserpin
inhibitor
tissu
factor
pathway
inhibitor
tfpi
macroglobulin
tfpi
consist
three
tandem
kunitztyp
domain
second
interact
activ
site
factor
xa
complex
associ
tissu
viia
form
inact
quaternari
complex
heterolog
protein
inhibitor
factor
xa
includ
soy
bean
corn
trypsin
inhibitor
well
protein
snake
venom
certain
peptid
natur
occur
eg
tick
anticoagul
peptid
ecotin
hookworm
peptid
synthet
eg
dansylilegluglyargch
cl
degr
directli
inhibit
factor
xa
addit
mani
specif
organ
inhibitor
factor
xa
identifi
includ
propano
acid
deriv
benzamidinebas
compound
synthet
inhibitor
develop
antithrombot
agent
includ
biarylmethoxi
isonipecotanilid
thiopheneanthranilamid
quinoxalinon
razaxaban
apixaban
rivaroxaban
darexaban
taken
oral
anticoagul
nematod
ancylostoma
caninum
bind
first
novel
exosit
factor
xa
inhibit
factor
viia
complex
tissu
factor
factor
xa
membranebound
factor
xxa
inactiv
plasmin
cleavag
bond
gener
factor
cleavag
peptid
bond
gener
factor
destroy
clot
activ
cleavag
expos
plasminogen
bind
site
augment
gener
plasmin
thu
seem
switch
factor
xxa
procoagul
anticoagul
role
stimul
fibrinolysi
primari
structur
human
factor
x
determin
amino
acid
dna
sequenc
factor
x
sequenc
sever
vertebr
speci
also
known
human
factor
x
synthes
singl
polypeptid
amino
acid
includ
signal
peptid
amino
acid
direct
transloc
lumen
endoplasm
reticulum
propeptid
amino
acid
serv
recognit
site
carboxylas
neither
found
matur
protein
prior
secret
tripeptid
excis
yield
heterodim
link
disulfid
bond
molecular
mass
matur
zymogen
kda
sediment
equilibrium
consist
light
chain
amino
acid
glycosyl
heavi
chain
amino
acid
resolv
sdspage
chain
appar
mass
kda
nterminu
heavi
chain
residu
constitut
activ
peptid
found
activ
enzym
nterminu
light
chain
amino
acid
compris
gla
domain
includ
socal
aromat
amino
acid
stack
gla
residu
resid
posit
aromat
stack
follow
two
egflik
domain
residu
structur
factor
xa
lack
gla
domain
solv
xray
crystallographi
resolut
overal
fold
catalyt
domain
similar
chymotrypsin
thrombin
contain
three
disulfid
bond
constitut
catalyt
triad
involv
hydrolyz
peptid
bond
substrat
primari
specif
pocket
form
two
loop
residu
join
disulfid
bond
aspartyl
residu
sit
base
pocket
characterist
trypsinlik
proteas
format
salt
bridg
arg
residu
posit
substrat
import
interact
explain
enzym
prefer
hydrolyz
substrat
ctermin
side
arg
residu
ctermin
egflik
domain
close
contact
catalyt
domain
like
ntermin
one
fold
similar
egflik
domain
fold
support
three
disulfid
bond
link
cy
residu
pattern
threedimension
structur
ntermin
egflik
domain
determin
presenc
absenc
calcium
ion
calciumbound
structur
reveal
calciumbind
site
uniqu
egflik
domain
identifi
ligand
calcium
ion
howev
requir
high
affin
calcium
bind
nmrbase
structur
show
also
calcium
ion
lock
egflik
domain
proper
posit
rel
gla
domain
structur
gla
domain
link
ntermin
egflik
domain
determin
absenc
calcium
nmr
spectroscopi
contrast
model
calciumbound
domain
structur
reveal
absenc
calcium
gla
residu
expos
solvent
three
hydrophob
residu
near
nterminu
fold
interior
domain
thu
bind
sever
calcium
ion
gla
domain
pull
gla
residu
interior
provid
energi
requir
expos
hydrophob
side
chain
solut
togeth
sitedirect
mutagenesi
studi
establish
interact
gla
domain
phospholipid
membran
includ
associ
hydrophob
natur
factor
x
purifi
homogen
plasma
use
convent
method
initi
precipit
base
affin
insolubl
barium
salt
usual
employ
often
follow
ammonium
sulfat
precipit
anion
exchang
chromatographi
procedur
suffici
obtain
homogen
bovin
factor
x
purif
human
factor
x
may
requir
addit
chromatographi
step
immunoaffin
chromatographi
monoclon
antibodi
also
util
success
recent
recombin
factor
x
express
sever
mammalian
cell
line
howev
high
express
level
proteolyt
process
ineffici
substitut
factor
x
propeptid
prothrombin
improv
chromatographi
hydroxyapatit
effect
isol
fulli
factor
x
sitedirect
mutagenesi
employ
enhanc
cleavag
propeptid
also
remov
incub
furin
factor
x
gene
locat
chromosom
posit
adjac
factor
vii
gene
span
kb
seven
intron
eight
exon
exon
encod
signal
peptid
exon
ii
propeptidegla
domain
exon
iii
ctermin
part
gla
domain
aromat
amino
acid
stack
exon
iv
v
egflik
domain
exon
vi
activ
peptid
region
exon
vii
viii
catalyt
domain
factor
x
synthes
mainli
liver
mrna
andor
protein
detect
sever
tissu
factor
x
secret
blood
normal
concentr
ml
protein
undergo
extens
posttransl
modif
signal
peptid
remov
signal
peptidas
transloc
endoplasm
reticulum
glu
residu
gla
domain
carboxylas
follow
proteolyt
remov
propeptid
subtilisinlik
enzym
furin
first
egflik
domain
convert
acid
dioxygenas
activ
peptid
oglycosyl
nglycosyl
olink
carbohydr
moieti
appear
import
factor
x
activ
effici
activ
peptid
bovin
factor
x
contain
sulfat
group
oesterifi
transgolgi
apparatu
factor
x
polypeptid
cleav
bond
yield
disulfidebond
dimer
three
ctermin
residu
light
chain
somehow
remov
either
secret
plasma
activ
factor
x
serin
proteas
occur
predominantli
hydrolysi
bond
heavi
chain
releas
activ
peptid
form
factor
cleavag
caus
new
nterminu
heavychain
rearrang
particip
format
substrat
bind
pocket
form
salt
bridg
also
contribut
format
na
factor
va
bind
site
appear
caus
transit
zymogen
activ
proteas
second
cleavag
plasminmedi
autocatalyt
bond
yield
factor
procoagul
activ
form
factor
xa
similar
activ
factor
x
occur
via
two
princip
pathway
activ
factor
viiviia
complex
nonenzymat
membranebound
cofactor
tissu
factor
tf
pathway
call
extrins
pathway
respons
initi
coagul
proceed
mainli
surfac
damag
endotheli
cell
macrophag
probabl
also
activ
platelet
altern
factor
x
activ
platelet
surfac
membranebound
tenas
complex
compris
factor
ixa
cofactor
factor
viiia
calcium
ion
activ
factor
x
b
fold
rapidli
factor
ixa
alon
intrins
pathway
respons
amplifi
coagul
process
see
also
chapter
import
illustr
fact
hereditari
defici
factor
ix
viii
caus
hemophilia
b
respect
thu
factor
x
play
pivot
role
blood
clot
point
converg
two
coagul
pathway
accordingli
sever
rare
mutat
factor
x
gene
identifi
give
rise
bleed
tendenc
variabl
sever
eg
chafa
et
al
bereczki
et
al
theoret
inject
factor
xa
patient
hemophilia
bypass
intrins
pathway
permit
gener
thrombin
fail
short
halflif
plasma
factor
xa
howev
mutant
replac
much
longer
halflif
form
complex
antithrombin
iii
tissu
factor
inhibitor
hemophiliac
plasma
yet
still
abl
activ
prothrombin
thu
may
use
therapeut
agent
factor
x
also
activ
altern
pathway
initi
surfac
leukocyt
trigger
clot
case
zymogen
bound
integrin
activ
occur
hydrolysi
peptid
bond
activ
peptid
cleavag
effect
cathepsin
g
secret
stimul
leukocyt
bind
factor
x
high
affin
k
b
nm
affin
factor
xa
enzym
present
venom
snake
eg
rvvx
chapter
toxic
anim
also
activ
factor
x
addit
direct
involv
blood
coagul
factor
xa
interact
signal
receptor
surfac
mani
type
cell
thu
elicit
varieti
respons
includ
cell
activ
gene
express
mitogenesi
factor
xa
receptor
term
effector
cell
proteas
structur
similar
light
chain
factor
v
clone
bind
factor
x
wherea
factor
xa
form
complex
induc
cytokin
gene
express
releas
plateletderiv
growth
factor
endotheli
cell
factor
xa
appear
exert
effect
dock
subsequ
cleav
activ
proteaseactiv
member
famili
g
proteincoupl
receptor
activ
cleavag
ntermin
peptid
new
nterminu
tether
ligand
insert
bodi
receptor
activ
also
evid
factor
xa
induc
cell
signal
vascular
wall
cell
activ
andor
mechan
independ
eg
mclean
et
al
factor
xa
activ
effect
epithelialderiv
tumor
cell
enter
apoptosi
breast
colon
lung
cancer
cell
migrat
inhibit
epitheli
cell
signal
via
extracellularsign
regul
kinas
erk
pathway
lead
upregul
bim
activ
breast
cancer
cell
rhorock
srcfakpaxillin
pathway
activ
lead
myosin
light
chain
phosphoryl
activ
cofilin
inactiv
stabil
actin
filament
incompat
cell
migrat
factor
xa
physiolog
patholog
role
express
bronchoalveolar
lavag
fluid
macrophag
mous
model
asthma
induc
mucin
product
factor
xa
mediat
attach
adenoviru
hepatocyt
via
hexon
protein
basic
residu
serin
peptidas
domain
essenti
interact
sar
coronaviru
spike
protein
bind
host
receptor
cleav
factor
xa
subunit
facilit
viral
infect
factor
x
liversynthes
zymogen
serin
proteas
requir
vitamin
k
normal
biosynthesi
protein
domain
structur
coagul
factor
vii
ix
protein
c
chapter
protein
z
although
synthes
singl
polypeptid
chain
factor
x
protein
c
cleav
form
dimer
prior
secret
protein
easili
distinguish
sdspage
reduc
condit
monoclon
polyclon
antibodi
distinguish
protein
commerci
avail
review
see
jame
menegatti
peyvandi
auerswald
review
factor
x
defici
brown
kouid
review
diagnosi
treatment
josic
et
al
review
method
prepar
vitamin
kdepend
peptidas
includ
factor
x
